501
Participants
Start Date
August 31, 2010
Primary Completion Date
January 31, 2012
Study Completion Date
January 31, 2012
iloperidone
Iloperidone tablets supplied at doses of 1 mg, 2 mg, 4 mg, 6 mg, 8 mg, 10 mg and 12 mg to achieve a target dose of 12-24 mg/day for 12 weeks.
Behavioral Medical Research, Staten Island
Richmond Behavioral Associates, Staten Island
Division of Psychiatry Research - Zucker Hills Hospital, Glen Oaks
Comprehensive Neuroscience, Fresh Meadows
Neurobehavioral Research, Cedarhurst
Finger Lakes Clinical Research, Rochester
Belmont Center for Comprehensive Treatment, Philadelphia
CRI Worldwide, LLC - Kirkbride Division, Philadelphia
Comprenhensive Neuroscience, Washington D.C.
Carolina Clinical Trials, Charleston
Northwest Behavioral Research Center, Marietta
Carman Research, Smyrna
Institute for Behavioral Medicine, Smyrna
Atlanta Center for Medical Research, Atlanta
Comprehensive Neuroscience, Atlanta
Amit K. Vijapura MD & Associates, Jacksonville
Scientific Clinical Research, North Miami
Birmingham Psychiatry Pharmaceutical Studies, Inc., Birmingham
Precise Research Centers, Flowood
North Coast Clinical Trials, Beachwood
Neurobehavioral Clinical Research, Canton
Neurobehavioral Medicine Group, Clinical Trials Division, Bloomfield Hills
Rochester Center for Behavioral Medicine, Rochester Hills
Alexian Brothers Center for Mental Health, Arlington Heights
Midwest Center for Neurobehavioral Medicine, Oakbrook Terrace
AMR - Baber Research, Inc., Naperville
Rush University Medical Center, Treatment Research Center, Chicago
University of Illinois at Chicago, Chicago
St. Charles Psychiatric Associates - Midwest Research Group, Saint Charles
Louisiana Clinical Research, Shreveport
IPS Research Company, Oklahoma City
SP Research, PLLC, Oklahoma City
Mary Ann Knesevich, MD, PA, Irving
InSite Clinical Research, Plano
InSite Clinical Research, DeSoto
KRK Medical Research, Dallas
FutureSearch Trials, Dallas
Bayou City Research Limited, Houston
Claghorn-Lesem Research Clinic, Inc, Houston
Community Clinical Research, Inc., Austin
Albuquerque Neuroscience, Albuquerque
Collaborative Neuroscience, Torrance
Comprehensive Neuroscience, Cerritos
Apostle Clinical Trials, Inc., Long Beach
Pacific Health Systems, National City
Excell Research, Inc., Oceanside
CNRI San Diego, San Diego
Affiliated Research Institute, San Diego
Artemis Institute for Clinical Research, San Diego
Viking Clinical Research, Temecula
ATP Clinical Research Center, Inc., Costa Mesa
Neuropsychiatric Research Center of Orange County, Santa Ana
Collaborative Neuroscience Network, Garden Grove
University of California, Irvine, Orange
Pacific Research Partners, Oakland
Frontier Institute, Spokane
The Hospital of Central Connecticut, New Britain
Center for Emotional Fitness, Cherry Hill
CRI World Wide Clinical Research Company, Willingboro
Lead Sponsor
Novartis
INDUSTRY